Sankar Subramanian 4
4 · Nautilus Biotechnology, Inc. · Filed Feb 25, 2022
Insider Transaction Report
Form 4
Sankar Subramanian
Senior VP, Product Development
Transactions
- Award
Stock Option (Right to Buy)
2022-02-25+140,000→ 140,000 totalExercise: $3.78Exp: 2032-02-25→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is February 25, 2022.